Abstract Submission

2021 CGC Annual Meeting Abstract Submission is Now Open

Abstract Deadline: March 1, 2021, 11:59 pm (Pacific Standard Time)
At this time, the CGC is planning a hybrid meeting, with both in-person and virtual options for abstract presentation.

Abstract Submission Instructions:

  • Abstract submission is for both Oncology and Constitutional topics. Suggested topics are found below. Abstracts will be considered outside these topics.
  • There is a 250 word limit on the text in the body of submitted abstracts.
  • Abstracts must be submitted by Monday, March 1, 2021, 11:59 PM (midnight) Pacific Standard Time.
  • Accepted abstracts will be designated as poster or platform presentations. 
  • All accepted abstracts will be published in Cancer Genetics.
  • Abstract acceptance notifications are expected to be sent on or before March 23, 2021.
  • Presenting authors of accepted abstracts must register and pay for meeting attendance by March 30, 2021 to secure abstract publication in Cancer Genetics.
  • While in the submission module, if you need to return to a previous page in the submission process, please use the back arrow on your browser.
  • If you have challenges with your submission, please email meetings@cancergenomics.org.

Abstract Submission Topics:

  • Bioinformatics
  • Hematologic Malignancies: Testing Algorithms, Cases, and/or Clinical Management
  • Solid Tumors: Testing Algorithms, Cases, and/or Clinical Management
  • Tumor Mutational Burden (Testing Algorithms, Cases, and/or Clinical Mgt.)
  • Hereditary Cancer Syndromes / Cancer Predisposition
  • Incidental Findings
  • Immunotherapy (Testing Algorithms, Cases, and/or Clinical Management)
  • Vascular Anomalies and Overgrowth Syndromes
  • Pharmacogenomics (Testing Algorithms, Cases, and/or Clinical Management)
  • Impact of COVID on Cancer Care
  • Technical Topics (e.g., Assay Validation, Mosaicism, Emerging Technologies, Liquid Biopsy, etc.)
  • Social and Ethical Considerations in Genomic Testing
  • Guidelines and Regulatory Compliance in Genomic Testing
  • Economic Affairs (e.g., Billing, Coding, Reimbursement)
  • Other Oncology and Constitutional Topics - If your abstract does not fit into one of the topics above, please don't hesitate to submit it